The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig

被引:48
作者
Louttit, JB [1 ]
Hunt, AAE [1 ]
Maxwell, MP [1 ]
Drew, GM [1 ]
机构
[1] Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Syst Biol Unit, Stevenage SG1 2NY, Herts, England
关键词
cardioprotection; adenosine A(1)-receptor; ischaemia; reperfusion; GR79236; pig;
D O I
10.1097/00005344-199902000-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cardioprotective effects of the selective adenosine A(1)-receptor agonist, GR79236 (N-[(1S, trans)-2-hydroxycyclopentyl]adenosine), were examined in a porcine model of myocardial ischaemia-reperfusion injury. When pigs were subjected to a 50-min coronary artery occlusion followed by 3-h reperfusion, GR79236 (10 nmol/kg, i.v.) significantly reduced infarct size whether given 10 min before the onset of ischaemia or reperfusion. This effect was independent of the bradycardia induced by GR79236, as it was also observed in animals in which heart rate was maintained by electrical pacing. However, GR79236 administered 10 min after reperfusion did not reduce infarct size. GR79236 had no effect on the incidence or outcome of ventricular dysrhythmias in this pig model of infarction. Similarly, ischaemic preconditioning (IPC, 2 x 10-min ischaemia and 10-min reperfusion) significantly reduced infarct size. The selective adenosine Al-receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 3.3 mu mol/kg, i.v.), abolished the haemodynamic and cardioprotective effects of GR79236 and the cardioprotective effects of IPC in anaesthetised pigs. In conclusion, GR79236 exerted a marked cardioprotective effect in a porcine model of myocardial ischaemia-reperfusion injury, provided that it was administered before reperfusion. This suggests that GR79236 may have clinical utility in the treatment of various aspects of ischaemic heart disease.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 29 条
[1]   PRECONDITIONING THE HUMAN HEART DURING AORTOCORONARY BYPASS-SURGERY [J].
ALKHULAIFI, AM ;
YELLON, DM ;
PUGSLEY, WB .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (05) :270-276
[2]   ADENOSINE-A(1) RECEPTORS, K(ATP) CHANNELS, AND ISCHEMIC PRECONDITIONING IN DOGS [J].
AUCHAMPACH, JA ;
GROSS, GJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :H1327-H1336
[3]   NORMOTHERMIC RANGE TEMPERATURE AFFECTS MYOCARDIAL INFARCT SIZE [J].
CHIEN, GL ;
WOLFF, RA ;
DAVIS, RF ;
VANWINKLE, DM .
CARDIOVASCULAR RESEARCH, 1994, 28 (07) :1014-1017
[4]   ADAPTATION TO ISCHEMIA DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL, HEMODYNAMIC, AND METABOLIC FEATURES [J].
DEUTSCH, E ;
BERGER, M ;
KUSSMAUL, WG ;
HIRSHFELD, JW ;
HERRMANN, HC ;
LASKEY, WK .
CIRCULATION, 1990, 82 (06) :2044-2051
[5]   ADENOSINE AND THE ANTI-INFARCT EFFECTS OF PRECONDITIONING [J].
DOWNEY, JM ;
LIU, GS ;
THORNTON, JD .
CARDIOVASCULAR RESEARCH, 1993, 27 (01) :3-8
[6]   Effect of temperature on myocardial infarction in swine [J].
Duncker, DJ ;
Klassen, CL ;
Ishibashi, Y ;
Herrlinger, SH ;
Pavek, TJ ;
Bache, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 270 (04) :H1189-H1199
[7]   Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A(1) receptor stimulation during reperfusion following ischaemia [J].
Finegan, BA ;
Lopaschuk, GD ;
Gandhi, M ;
Clanachan, AS .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :355-363
[8]   EARLY PHASE ACUTE MYOCARDIAL INFARCT SIZE QUANTIFICATION - VALIDATION OF THE TRIPHENYL TETRAZOLIUM CHLORIDE TISSUE ENZYME STAINING TECHNIQUE [J].
FISHBEIN, MC ;
MEERBAUM, S ;
RIT, J ;
LANDO, U ;
KANMATSUSE, K ;
MERCIER, JC ;
CORDAY, E ;
GANZ, W .
AMERICAN HEART JOURNAL, 1981, 101 (05) :593-600
[9]   THE EFFECTS OF GR79236 ON PLASMA FATTY-ACID CONCENTRATIONS, HEART-RATE AND BLOOD-PRESSURE IN THE CONSCIOUS RAT [J].
GARDNER, CJ ;
TWISSELL, DJ ;
COATES, J ;
STRONG, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (1-2) :117-121
[10]   FUNCTIONAL-CHARACTERIZATION OF 3 ADENOSINE RECEPTOR TYPES [J].
GURDEN, MF ;
COATES, J ;
ELLIS, F ;
EVANS, B ;
FOSTER, M ;
HORNBY, E ;
KENNEDY, I ;
MARTIN, DP ;
STRONG, P ;
VARDEY, CJ ;
WHEELDON, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) :693-698